Assets, Ethereum

Is Injective Protocol Built on Ethereum?

Injective Protocol is an open-source, decentralized protocol that enables anyone to trade any digital asset on any derivatives exchange. The protocol is built on Ethereum and provides a decentralized, trustless, and secure way to trade. Injective Protocol is the first layer-2 decentralized exchange protocol that supports both spot and derivatives trading.

The protocol is designed to be easily integrated into existing exchanges and wallets, allowing users to trade directly from their wallets. Injective Protocol is currently live on Ethereum mainnet and is available for trading.

The Injective Protocol team consists of experienced developers and researchers who have been building decentralized applications on Ethereum for years. The team is led by CEO and Co-founder Eric Chen, who has a background in computer science and has experience working at Google, Facebook, and Bloomberg.

The Injective Protocol whitepaper was released in 2019 and outlines the technical details of the protocol.

NOTE: WARNING: The Injective Protocol is not built on Ethereum, but instead is built on a Cosmos-SDK blockchain. This means that the Injective Protocol is not compatible with existing Ethereum applications, and using it may lead to incompatibility issues. It is strongly advised to thoroughly research any protocol before using it to ensure maximum compatibility.

Injective Protocol is built on Ethereum and utilizes smart contracts to enable decentralized trading on the platform. The protocol uses a relayer architecture that allows for order book sharing among different exchanges.

This allows users to access liquidity from multiple exchanges through a single interface. Injective Protocol also uses an off-chain order matching engine that executes trades quickly and efficiently.

The Injective Protocol token (INJ) is an ERC20 token that is used to pay fees on the platform. INJ tokens are required to stake liquidity providers and to pay transaction fees.

INJ tokens are also used to vote on governance decisions relating to the protocol. The Injective Protocol Foundation holds a total of 10% of all INJ tokens.

The Injective Protocol team has raised $5 million from leading investors in the space including Pantera Capital, BlockTower Capital, Galaxy Digital Ventures, Hashkey Group, Kenetic Capital, Libertus Capital, Arrington XRP Capital, Hashed, CMS Holdings, Divergence Digital Currency Fund, Spartan Group, Hypersphere Ventures, Mechanism Capital, StakewithUS Ventures, Reflective Venture Partners, Blockchain Valley Ventures, Distributed Global Fund (DGF), Fenbushi Digital Ventures Fund III LP., colloquially known as “3L”.

Previous ArticleNext Article